NR1H4 and intestinal cancer: It was reported that FXR, a nuclear receptor, is a critical regulator of intestinal cancer stem cell proliferation and may be a potential therapeutic target for treating colorectal cancer.[44] However, the role of FXR in MSC‐based therapy for heart repair has never been studied.